These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 18468741

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Oral immunization with a combination of Plasmodium yoelii merozoite surface proteins 1 and 4/5 enhances protection against lethal malaria challenge.
    Wang L, Goschnick MW, Coppel RL.
    Infect Immun; 2004 Oct; 72(10):6172-5. PubMed ID: 15385527
    [Abstract] [Full Text] [Related]

  • 4. AAV vectors encoding malarial antigens stimulate antigen-specific immunity but do not protect from parasite infection.
    Logan GJ, Wang L, Zheng M, Cunningham SC, Coppel RL, Alexander IE.
    Vaccine; 2007 Jan 22; 25(6):1014-22. PubMed ID: 17081661
    [Abstract] [Full Text] [Related]

  • 5. Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells.
    Hirunpetcharat C, Tian JH, Kaslow DC, van Rooijen N, Kumar S, Berzofsky JA, Miller LH, Good MF.
    J Immunol; 1997 Oct 01; 159(7):3400-11. PubMed ID: 9317139
    [Abstract] [Full Text] [Related]

  • 6. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.
    Wang R, Charoenvit Y, Corradin G, Porrozzi R, Hunter RL, Glenn G, Alving CR, Church P, Hoffman SL.
    J Immunol; 1995 Mar 15; 154(6):2784-93. PubMed ID: 7876549
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
    Rainczuk A, Scorza T, Spithill TW, Smooker PM.
    Infect Immun; 2004 Oct 15; 72(10):5565-73. PubMed ID: 15385453
    [Abstract] [Full Text] [Related]

  • 9. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV, Biswas S, Pillai CR, Saxena RK.
    Vaccine; 2008 Aug 18; 26(35):4526-35. PubMed ID: 18590786
    [Abstract] [Full Text] [Related]

  • 10. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity.
    Dobaño C, Sedegah M, Rogers WO, Kumar S, Zheng H, Hoffman SL, Doolan DL.
    Exp Parasitol; 2009 Jun 18; 122(2):112-23. PubMed ID: 19249301
    [Abstract] [Full Text] [Related]

  • 11. Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model.
    Rotman HL, Daly TM, Clynes R, Long CA.
    J Immunol; 1998 Aug 15; 161(4):1908-12. PubMed ID: 9712060
    [Abstract] [Full Text] [Related]

  • 12. Plasmodium yoelii: experimental evidences for the conserved epitopes between mouse and human malaria parasite, Plasmodium falciparum.
    Xu L, Pei X, Berzins K, Chaudhuri A.
    Exp Parasitol; 2007 Jul 15; 116(3):214-24. PubMed ID: 17336297
    [Abstract] [Full Text] [Related]

  • 13. A protective monoclonal antibody recognizes an epitope in the carboxyl-terminal cysteine-rich domain in the precursor of the major merozoite surface antigen of the rodent malarial parasite, Plasmodium yoelii.
    Burns JM, Majarian WR, Young JF, Daly TM, Long CA.
    J Immunol; 1989 Oct 15; 143(8):2670-6. PubMed ID: 2477452
    [Abstract] [Full Text] [Related]

  • 14. Prophylactic potential of liposomized integral membrane protein of Plasmodium yoelii nigeriensis against blood stage infection in BALB/c mice.
    Sharma SK, Gupta C, Dwivedi V, Misra-Bhattacharya S, Mohammad O.
    Vaccine; 2007 Mar 01; 25(11):2103-11. PubMed ID: 17241709
    [Abstract] [Full Text] [Related]

  • 15. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C, Doolan DL.
    Mol Immunol; 2007 Apr 01; 44(11):3037-48. PubMed ID: 17303242
    [Abstract] [Full Text] [Related]

  • 16. Absolute requirement for an active immune response involving B cells and Th cells in immunity to Plasmodium yoelii passively acquired with antibodies to the 19-kDa carboxyl-terminal fragment of merozoite surface protein-1.
    Hirunpetcharat C, Vukovic P, Liu XQ, Kaslow DC, Miller LH, Good MF.
    J Immunol; 1999 Jun 15; 162(12):7309-14. PubMed ID: 10358180
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge.
    Sauzet JP, Perlaza BL, Brahimi K, Daubersies P, Druilhe P.
    Infect Immun; 2001 Feb 15; 69(2):1202-6. PubMed ID: 11160023
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity.
    Bongfen SE, Ntsama PM, Offner S, Smith T, Felger I, Tanner M, Alonso P, Nebie I, Romero JF, Silvie O, Torgler R, Corradin G.
    Vaccine; 2009 Jan 07; 27(2):328-35. PubMed ID: 18984024
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.